Informa plc (LON:INF) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Informa plc (LON:INF) have earned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is GBX 1,093.33.

Several equities research analysts recently commented on INF shares. Citigroup cut their target price on shares of Informa from GBX 1,000 to GBX 850 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. JPMorgan Chase & Co. decreased their price target on shares of Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research report on Thursday, July 2nd.

Informa Stock Performance

Informa stock opened at GBX 894.46 on Monday. The business has a 50 day moving average of GBX 838.90 and a 200-day moving average of GBX 832.94. Informa has a 1 year low of GBX 719 and a 1 year high of GBX 1,000. The company has a debt-to-equity ratio of 61.56, a current ratio of 0.44 and a quick ratio of 1.70. The company has a market capitalization of £11.22 billion, a P/E ratio of 1,118.08, a P/E/G ratio of 0.75 and a beta of 0.69.

Insider Buying and Selling at Informa

In related news, insider Stephen A. Carter bought 222 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were purchased at an average cost of GBX 809 per share, with a total value of £1,795.98. Also, insider Gareth Wright purchased 222 shares of the firm’s stock in a transaction on Wednesday, May 20th. The shares were acquired at an average price of GBX 809 per share, with a total value of £1,795.98. 0.39% of the stock is owned by company insiders.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.